Gabrilovich DI - Search Results

1

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.

Alicea-Torres K, Sanseviero E, Gui J, Chen J, Veglia F, Yu Q, Donthireddy L, Kossenkov A, Lin C, Fu S, Mulligan C, Nam B, Masters G, Denstman F, Bennett J, Hockstein N, Rynda-Apple A, Nefedova Y, Fuchs SY, Gabrilovich DI. Alicea-Torres K, et al. Among authors: gabrilovich di. Nat Commun. 2021 Mar 19;12(1):1717. doi: 10.1038/s41467-021-22033-2. Nat Commun. 2021. PMID: 33741967 Free PMC article.

2

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.

Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D. Yu B, et al. Clin Cancer Res. 2003 Jan;9(1):285-94. Clin Cancer Res. 2003. PMID: 12538481

3

Notch signaling is necessary but not sufficient for differentiation of dendritic cells.

Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Cheng P, et al. Blood. 2003 Dec 1;102(12):3980-8. doi: 10.1182/blood-2003-04-1034. Epub 2003 Aug 7. Blood. 2003. PMID: 12907456 Free article.

4

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. Kusmartsev S, et al. Cancer Res. 2003 Aug 1;63(15):4441-9. Cancer Res. 2003. PMID: 12907617

5

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Nefedova Y, et al. Among authors: gabrilovich di. Blood. 2004 May 1;103(9):3503-10. doi: 10.1182/blood-2003-07-2340. Epub 2003 Dec 11. Blood. 2004. PMID: 14670925 Free article.

6

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Nefedova Y, et al. J Immunol. 2004 Jan 1;172(1):464-74. doi: 10.4049/jimmunol.172.1.464. J Immunol. 2004. PMID: 14688356

7

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Kusmartsev S, et al. Among authors: gabrilovich di. J Immunol. 2004 Jan 15;172(2):989-99. doi: 10.4049/jimmunol.172.2.989. J Immunol. 2004. PMID: 14707072

8

Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Kusmartsev S, Gabrilovich DI. Kusmartsev S, et al. Among authors: gabrilovich di. Cancer Immunol Immunother. 2006 Mar;55(3):237-45. doi: 10.1007/s00262-005-0048-z. Epub 2005 Jul 27. Cancer Immunol Immunother. 2006. PMID: 16047143 Free PMC article. Review.

9

Activation of dendritic cells via inhibition of Jak2/STAT3 signaling.

Nefedova Y, Cheng P, Gilkes D, Blaskovich M, Beg AA, Sebti SM, Gabrilovich DI. Nefedova Y, et al. Among authors: gabrilovich di. J Immunol. 2005 Oct 1;175(7):4338-46. doi: 10.4049/jimmunol.175.7.4338. J Immunol. 2005. PMID: 16177074 Free PMC article.

10

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.

Kusmartsev S, Nagaraj S, Gabrilovich DI. Kusmartsev S, et al. Among authors: gabrilovich di. J Immunol. 2005 Oct 1;175(7):4583-92. doi: 10.4049/jimmunol.175.7.4583. J Immunol. 2005. PMID: 16177103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters